Sfoglia per AUTORE
FRESA A
Collezione AOU Novara

  

Items : 3

Venetoclax based regimens in octogenarian CLL patients: efficacy, safety and comparison to BTKi in a multicenter cohort. in Blood advances / Blood Adv. 2025 Apr 16:bloodadvances.2025015818. doi: 10.1182/bloodadvances.2025015818.
2025
AOU Novara

Serafin A; Cellini A; Martino EA; Mazzetto F; Angotzi F; Frustaci AM; Marchetti M; Moia R; Sanna A; Riemma C; Cibien F; Noto A; Lista E; Foglietta M; Vitale C; Innao V; Bullo M; Lovato E; Ferrarini I; Andriola C; Ballotta L; Innocenti I; Fresa A; Favrin G; Varettoni M; Santambrogio E; Orsucci L; Pasquale R; Moratti M; et alii...

Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY. in EClinicalMedicine / EClinicalMedicine. 2023 Nov 15;65:102307. doi: 10.1016/j.eclinm.2023.102307. eCollection 2023 Nov.
2023
AOU Città della Salute di Torino
AOU Novara

Claus R; Biderman B; Antic D; Angelopoulou M; Zuchnicka J; Yassin M; Yañez L; Yagci M; Xu Z; Wasik-Szczepanek E; Walewska R; Vukovic V; Vrachiolias G; von Tresckow J; Vitale C; Visentin A; Vassilakopoulos T; Tomic K; Tse E; Spacek M; Tadmor T; Abdelrahman Soliman DS; Smirnova S; Simkovic M; Shen Y; Schiwitza A; Schipani M; Daniel de Deus Santos M; Ruchlemer R; et alii...

Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia study. in Hematological oncology / Hematol Oncol. 2023 Dec;41(5):877-883. doi: 10.1002/hon.3199. Epub 2023 Jul 1.
2023
AOU Città della Salute di Torino
AOU Novara

Cuneo A; Foà R; Trentin L; Gattei V; Coscia M; Mattiello V; Rigolin GM; Gentile M; Moia R; Scortechini I; Sportoletti P; Catania G; Loseto G; Chiurazzi F; Malerba L; De Paolis MR; Angeletti I; Ferrari A; Giordano A; Baratè C; Quaresmini G; Farina L; Fresa A; Leone MMA; Piciocchi A; Vitale C; Visentin A; Reda G; Innocenti I; et alii...